Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Neoplasm Female × Letrozole × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 288 Polycystic Ovary Syndrome 31 Endometrial Neoplasms 19 Neoplasm Metastasis 17 Ovarian Neoplasms 14 Neoplasms 8 Infertility 7 Fallopian Tube Neoplasms 7 Recurrence 6 Carcinoma, Intraductal, Noninfiltrating 6 Breast Neoplasms, Male 6 Advanced Breast Cancer 6 Triple Negative Breast Neoplasms 5 Carcinoma, Lobular 5 Carcinoma, Ductal, Breast 5 Prostatic Neoplasms 4 Osteoporosis 4 Leiomyoma 4 Hereditary Sensory and Autonomic Neuropathies 4 Breast Carcinoma In Situ 4 Breast Cancer Metastatic 4 Neoplasms, Hormone-Dependent 3 Infertility, Female 3 Carcinoma, Ovarian Epithelial 3 Breast Diseases 3 Uterine Neoplasms 2 Uterine Cervical Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Solid Tumor 2 Pancreatic Neoplasms 2

Interventions

venetoclax 1 pyrotinib 1 pertuzumab 1 palbociclib 1 dalpiciclib 1 anlotinib 1 Tretinoin 1 Trastuzumab 1 Ropivacaine 1 Radiosurgery 1 Propofol 1 Paclitaxel 1 Ondansetron 1 Morphine 1 Letrozole 1 Induction Chemotherapy 1 Fulvestrant 1 Etoricoxib 1 Docetaxel 1 Diagnostic Imaging 1 Carboplatin 1 Capecitabine 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03900884 2024-11-07

PALVEN

Peter MacCallum Cancer Centre, Australia

Phase 1 Active not recruiting

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡